WBI Investments’s Biogen BIIB Stock Holding History

WBI Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10,373	Closed	-$3.28M	–	104
2020 Q1	$3.28M	Buy	+10,373	New	+$3.15M	0.62%	19

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

WBI Investments's BIIB Position: Q2 2020 in Review

WBI Investments sold out of Biogen (BIIB) in Q2 2020, closing a stake of 10,373 shares — an estimated $3.28M sold.

WBI Investments first reported a position in BIIB in Q1 2020 and held it in 1 quarter. The position peaked at $3.28M in Q1 2020. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

WBI Investments reported no remaining Biogen position as of Q2 2020 after selling out during the quarter.
WBI Investments sold 10,373 Biogen shares in Q2 2020, an estimated $3.28M.
WBI Investments first reported a position in Biogen in Q1 2020 and held it in 1 quarter.
WBI Investments's Biogen position peaked at $3.28M in Q1 2020.
1,059 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on WBI Investments's 13F filing for Q2 2020, filed 11 Aug 2020.